Inventor · disambiguated record
Tobias Litzenburger
Also filed as: LITZENBURGER TOBIAS
9 granted patents·12 pending applications·149 citations·filing 2009–2023
89Inventor score
Files withBOEHRINGER INGELHEIM INT7VAN RYN JOANNE4ALTRUBIO INC2BARRETT RACHEL REBECCA2LITZENBURGER TOBIAS2
Top patents by PatentIndex Score
21 records- 0196US8591900B2Anti-CD40 antibodiesBARRETT RACHEL REBECCA·Filed 2011·Granted Nov 26, 2013·53 cites·42 claims
- 0295US9090696B2Polynucleotides encoding anti-CD40 antibodiesBARRETT RACHEL REBECCA·Filed 2013·Granted Jul 28, 2015·33 cites·4 claims
- 0393US8486398B2Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compoundsVAN RYN JOANNE·Filed 2011·Granted Jul 16, 2013·27 cites·31 claims
- 0487US9034822B2Methods of using antibodies during anticoagulant therapy of dabigatran and/or related compoundsVAN RYN JOANNE·Filed 2013·Granted May 19, 2015·10 cites·9 claims
- 0587US8821871B2Anticoagulant antidotes comprising antibodies that bind dabigatran and/or related compounds and methods of use thereofVAN RYN JOANNE·Filed 2012·Granted Sep 2, 2014·12 cites·19 claims
- 0686US11242394B2Anti-CD40 antibodiesBOEHRINGER INGELHEIM INT·Filed 2018·Granted Feb 8, 2022·3 cites·43 claims
- 0783US11897964B2Anti-PSGL-1 antibodies and uses thereofALTRUBIO INC·Filed 2021·Granted Feb 13, 2024·1 cites·5 claims
- 0881US9090695B2Antibodies for guanylyl cyclase receptorsWATERMAN ALISA·Filed 2009·Granted Jul 28, 2015·10 cites·3 claims
- 0979US2022153857A1Anti-cd40 antibodiesBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 1077US2024124604A1Anti-psgl-1 antibodies and uses thereofALTRUBIO INC·Filed 2023·Application pending·0 cites
- 1161US2017058039A1Anti-cd40 antibodiesBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 1260US2016222124A1Anti-cd40 antibodiesBOEHRINGER INGELHEIM INT·Filed 2016·Application pending·0 cites
- 1357US2015315282A1Anti-cd40 antibodiesBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 1454US2013251708A1Anti-psgl-1 antibodies and uses thereofABGENOMICS COOPERATIEF UA·Filed 2013·Application pending·0 cites
- 1554US2010119506A1Effectors of PAR-2 Activation and Their Use in the Modulation of InflammationBOEHRINGER INGELHEIM INT·Filed 2009·Application pending·0 cites
- 1651US2014377265A1Anticoagulant antidotesVAN RYN JOANNE·Filed 2014·Application pending·0 cites
- 1750US2013209449A9Anti-psgl-1 antibodies and uses thereofBASSARAB STEFAN·Filed 2012·Application pending·0 cites
- 1846US2015210778A1Anticoagulant antidotesBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 1939US9499633B2Dabigatran antidotesLITZENBURGER TOBIAS·Filed 2014·Granted Nov 22, 2016·0 cites·16 claims
- 2039US2016168251A1Antibodies for guanylyl cyclase receptorsMORPHOSYS AG·Filed 2015·Application pending·0 cites
- 2133US2011311553A1Effectors of PAR-2 Activation and Their Use in the Modulation of InflammationLITZENBURGER TOBIAS·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tobias Litzenburger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →